Literature DB >> 2016484

Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: a necropsy study of 20 patients.

B F Waller1, C A Pinkerton, C M Orr, J D Slack, J W VanTassel, T Peters.   

Abstract

This report describes clinical, morphologic and histologic findings at necropsy late (range 1.6 to 24.1 months [average 8.2 months]) after clinically successful coronary balloon angioplasty in 20 patients with coronary angioplasty restenosis. Clinical evidence of restenosis occurred in 14 patients (70%), including 6 patients with sudden coronary death. Of the 20 patients, 14 (70%) had a cardiac cause of death and 6 (30%) had a noncardiac cause of death. Two major subgroups of histologic findings were observed: 1) intimal proliferation (60%), and 2) atherosclerotic plaque only (40%). Of the eight sites with atherosclerotic plaque only, six were eccentric lesions and two were concentric lesions. No morphologic evidence of previous angioplasty injury (cracks, breaks, tears) was observed in the eight patients with atherosclerotic plaque only. Proposed mechanisms for the development of intimal proliferation involve the reaction of smooth muscle cells and platelets, whereas elastic recoil of overstretched eccentric or concentric atherosclerotic lesions represents the most likely explanation for the findings in the latter subgroup. On the basis of these morphologic findings at angioplasty restenosis sites, specific treatment strategies for restenosis after coronary artery balloon angioplasty are proposed.

Entities:  

Mesh:

Year:  1991        PMID: 2016484     DOI: 10.1016/0735-1097(91)90940-b

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  9 in total

1.  Early lumen diameter loss after percutaneous transluminal coronary angioplasty is related to coronary plaque burden: a role for viscous plaque properties in early lumen diameter loss.

Authors:  W E Kok; R J Peters; G Pasterkamp; R A van Liebergen; J J Piek; K T Koch; C A Visser
Journal:  Int J Cardiovasc Imaging       Date:  2001-04       Impact factor: 2.357

Review 2.  In-stent stenosis: pathology and implications for the development of drug eluting stents.

Authors:  Martin R Bennett
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

3.  Lipids, atherosclerosis, and restenosis after percutaneous transluminal coronary angioplasty.

Authors:  J J Ferguson; J T Willerson
Journal:  Tex Heart Inst J       Date:  1992

4.  Coagulation factors X, Xa, and protein S as potent mitogens of cultured aortic smooth muscle cells.

Authors:  G P Gasic; C P Arenas; T B Gasic; G J Gasic
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

5.  Inhibition of rabbit aortic smooth muscle cell proliferation by selective inhibitors of protein kinase C.

Authors:  A C Newby; K Lim; M A Evans; N P Brindle; R F Booth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

6.  Molecular atherectomy for restenosis.

Authors:  W Casscells; D A Lappi; A Baird
Journal:  Trends Cardiovasc Med       Date:  1993 Nov-Dec       Impact factor: 6.677

Review 7.  Mechanisms of restenosis.

Authors:  W Casscells; D Engler; J T Willerson
Journal:  Tex Heart Inst J       Date:  1994

8.  Coagulation factor Xa stimulates platelet-derived growth factor release and mitogenesis in cultured vascular smooth muscle cells of rat.

Authors:  F N Ko; Y C Yang; S C Huang; J T Ou
Journal:  J Clin Invest       Date:  1996-09-15       Impact factor: 14.808

9.  Antiplatelet and anticoagulant therapy in elective percutaneous coronary intervention.

Authors:  Jurriën M ten Berg; HW Thijs Plokker; Freek WA Verheugt
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.